| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/19/2023 | 31.1% | Oppenheimer | $100 → $98 | Maintains | Outperform |
| 10/11/2023 | 12.37% | UBS | $110 → $84 | Downgrades | Buy → Neutral |
| 10/05/2023 | 23.08% | JP Morgan | $93 → $92 | Maintains | Overweight |
| 09/26/2023 | 33.78% | Oppenheimer | $105 → $100 | Maintains | Outperform |
| 09/25/2023 | 20.4% | RBC Capital | → $90 | Reiterates | Sector Perform → Sector Perform |
| 09/07/2023 | 32.44% | HSBC | → $99 | Initiates Coverage On | → Buy |
| 08/18/2023 | 40.47% | Oppenheimer | $110 → $105 | Maintains | Outperform |
| 08/01/2023 | 20.4% | Atlantic Equities | $85 → $90 | Maintains | Neutral |
| 07/19/2023 | 37.79% | BMO Capital | $100 → $103 | Maintains | Outperform |
| 07/19/2023 | 47.16% | Oppenheimer | $97 → $110 | Maintains | Outperform |
| 07/12/2023 | 25.75% | Odeon Capital | → $94 | Upgrades | Hold → Buy |
| 07/07/2023 | 21.74% | JP Morgan | $97 → $91 | Maintains | Overweight |
| 06/22/2023 | 20.4% | Citigroup | $95 → $90 | Maintains | Neutral |
| 06/15/2023 | 27.09% | Citigroup | → $95 | Reiterates | Neutral → Neutral |
| 04/20/2023 | 39.13% | BMO Capital | $108 → $104 | Maintains | Outperform |
| 04/20/2023 | 37.79% | Oppenheimer | $95 → $103 | Maintains | Outperform |
| 04/20/2023 | 27.09% | Citigroup | $100 → $95 | Maintains | Neutral |
| 04/19/2023 | 40.47% | CFRA | → $105 | Reiterates | → Strong Buy |
| 04/12/2023 | 49.83% | Barclays | $125 → $112 | Maintains | Overweight |
| 04/05/2023 | 39.13% | Evercore ISI Group | $106 → $104 | Maintains | Outperform |
| 04/03/2023 | 13.71% | Wells Fargo | $89 → $85 | Maintains | Equal-Weight |
| 03/24/2023 | 7.02% | RBC Capital | $90 → $80 | Maintains | Sector Perform |
| 03/23/2023 | 27.09% | Oppenheimer | $107 → $95 | Maintains | Outperform |
| 03/14/2023 | — | CFRA | Upgrades | Hold → Strong Buy | |
| 02/02/2023 | 43.14% | Oppenheimer | $102 → $107 | Maintains | Outperform |
| 01/19/2023 | 36.45% | Credit Suisse | $97 → $102 | Maintains | Outperform |
| 01/18/2023 | 41.81% | Evercore ISI Group | $90 → $106 | Maintains | Outperform |
| 01/18/2023 | 19.06% | Wells Fargo | $83 → $89 | Maintains | Equal-Weight |
| 01/18/2023 | 36.45% | Oppenheimer | $97 → $102 | Maintains | Outperform |
| 01/18/2023 | 45.82% | BMO Capital | $98 → $109 | Maintains | Outperform |
| 01/18/2023 | 33.78% | Citigroup | → $100 | Downgrades | Buy → Neutral |
| 01/17/2023 | 27.09% | CFRA | $90 → $95 | Reiterates | → Hold |
| 01/10/2023 | 18.73% | Odeon Capital | → $88.75 | Upgrades | Sell → Hold |
| 01/09/2023 | 31.1% | UBS | $90 → $98 | Maintains | Buy |
| 01/04/2023 | 23.08% | Wolfe Research | → $92 | Downgrades | Outperform → Underperform |
| 01/03/2023 | 67.22% | Barclays | $105 → $125 | Maintains | Overweight |
| 12/28/2022 | 29.77% | Oppenheimer | $102 → $97 | Maintains | Outperform |
| 12/20/2022 | 33.78% | Citigroup | $90 → $100 | Maintains | Buy |
| 12/06/2022 | 33.78% | JP Morgan | $95 → $100 | Maintains | Overweight |
| 10/18/2022 | 27.09% | BMO Capital | $97 → $95 | Maintains | Outperform |
| 10/17/2022 | 17.73% | Oppenheimer | $93 → $88 | Maintains | Outperform |
| 10/17/2022 | 20.4% | Citigroup | $97 → $90 | Maintains | Buy |
| 10/17/2022 | 40.47% | Barclays | $108 → $105 | Maintains | Overweight |
| 10/05/2022 | 13.71% | Atlantic Equities | → $85 | Downgrades | Overweight → Neutral |
| 10/04/2022 | 24.41% | Goldman Sachs | $94 → $93 | Maintains | Buy |
| 09/21/2022 | 25.75% | Goldman Sachs | $85 → $94 | Maintains | Buy |
| 09/21/2022 | 29.77% | Credit Suisse | $95 → $97 | Maintains | Outperform |
| 09/12/2022 | 23.08% | Deutsche Bank | $105 → $92 | Maintains | Hold |
| 09/06/2022 | — | Odeon Capital | Downgrades | Hold → Sell | |
| 07/15/2022 | 32.44% | BMO Capital | $105 → $99 | Maintains | Outperform |
| 07/15/2022 | 24.41% | Oppenheimer | $97 → $93 | Maintains | Outperform |
| 07/15/2022 | 44.48% | Barclays | $123 → $108 | Maintains | Overweight |
| 07/05/2022 | 27.09% | Credit Suisse | $100 → $95 | Maintains | Outperform |
| 07/01/2022 | 11.04% | Wells Fargo | $91 → $83 | Maintains | Equal-Weight |
| 07/01/2022 | 20.4% | Piper Sandler | $100 → $90 | Maintains | Neutral |
| 06/28/2022 | 7.02% | RBC Capital | $97 → $80 | Maintains | Sector Perform |
| 05/03/2022 | — | Oppenheimer | Upgrades | Perform → Outperform | |
| 04/18/2022 | 51.17% | BMO Capital | $110 → $113 | Maintains | Outperform |
| 04/05/2022 | 33.78% | Piper Sandler | $112 → $100 | Maintains | Neutral |
| 04/04/2022 | 25.75% | Wells Fargo | $104 → $94 | Maintains | Equal-Weight |
| 01/28/2022 | — | Odeon Capital | Downgrades | Buy → Hold | |
| 01/04/2022 | 67.22% | UBS | $119 → $125 | Maintains | Buy |
| 01/03/2022 | 64.55% | Barclays | $110 → $123 | Maintains | Overweight |
| 12/03/2021 | 53.85% | Citigroup | $105 → $115 | Upgrades | Neutral → Buy |
| 10/25/2021 | 39.13% | Wells Fargo | $102 → $104 | Maintains | Equal-Weight |
| 10/15/2021 | 47.16% | Barclays | $98 → $110 | Maintains | Overweight |
| 10/15/2021 | 49.83% | Credit Suisse | $108 → $112 | Maintains | Outperform |
| 10/15/2021 | — | RBC Capital | Downgrades | Outperform → Sector Perform | |
| 10/04/2021 | 31.1% | Wells Fargo | $89 → $98 | Maintains | Equal-Weight |
| 09/29/2021 | — | Oppenheimer | Downgrades | Outperform → Perform | |
| 09/28/2021 | 27.09% | Berenberg | $91 → $95 | Downgrades | Buy → Hold |
| 08/13/2021 | — | Seaport Global | Downgrades | Buy → Neutral | |
| 07/19/2021 | 29.77% | Citigroup | $88 → $97 | Maintains | Neutral |
| 07/16/2021 | 33.78% | Piper Sandler | $93 → $100 | Maintains | Neutral |
| 07/16/2021 | 37.79% | BMO Capital | $97 → $103 | Maintains | Outperform |
| 07/16/2021 | 40.47% | Argus Research | $93 → $105 | Maintains | Buy |
| 07/16/2021 | 40.47% | Oppenheimer | $99 → $105 | Maintains | Outperform |
| 07/07/2021 | 29.77% | RBC Capital | $82 → $97 | Maintains | Outperform |
| 06/16/2021 | 40.47% | JP Morgan | $85 → $105 | Maintains | Overweight |
| 06/09/2021 | 44.48% | Jefferies | → $108 | Initiates Coverage On | → Buy |
| 06/04/2021 | 40.47% | B of A Securities | $92 → $105 | Maintains | Buy |
| 06/01/2021 | 24.41% | Piper Sandler | $87 → $93 | Maintains | Neutral |
| 04/21/2021 | 21.74% | Berenberg | → $91 | Upgrades | Hold → Buy |
| 04/20/2021 | 16.39% | Piper Sandler | $82 → $87 | Maintains | Neutral |
| 04/19/2021 | 9.7% | RBC Capital | $78 → $82 | Maintains | Outperform |
| 04/01/2021 | 23.08% | UBS | $84 → $92 | Maintains | Buy |
| 04/01/2021 | 5.69% | Deutsche Bank | $68 → $79 | Maintains | Hold |
| 03/02/2021 | 15.05% | Daiwa Capital | → $86 | Upgrades | Neutral → Outperform |
| 01/25/2021 | 12.37% | Credit Suisse | $74 → $84 | Maintains | Outperform |
| 01/04/2021 | — | Barclays | Upgrades | Equal-Weight → Overweight | |
| 10/16/2020 | -19.73% | B of A Securities | $58 → $60 | Maintains | Buy |
| 10/16/2020 | -19.73% | Credit Suisse | $58 → $60 | Maintains | Outperform |
| 07/27/2020 | -22.41% | Citigroup | $56 → $58 | Maintains | Buy |
| 07/17/2020 | -31.77% | Piper Sandler | $48 → $51 | Maintains | Neutral |
| 07/17/2020 | -22.41% | Credit Suisse | $46 → $58 | Maintains | Outperform |
| 07/10/2020 | -27.76% | B of A Securities | $50 → $54 | Maintains | Buy |
| 07/08/2020 | -18.39% | Seaport Global | → $61 | Initiates Coverage On | → Buy |
| 06/24/2020 | -22.41% | DA Davidson | → $58 | Upgrades | Neutral → Buy |
| 04/17/2020 | -35.79% | Argus Research | $64 → $48 | Maintains | Buy |
| 04/17/2020 | -31.77% | Oppenheimer | $46 → $51 | Maintains | Outperform |
| 04/16/2020 | -41.14% | CFRA | $59 → $44 | Reiterates | → Hold |
| 04/06/2020 | -46.49% | Wells Fargo | $41 → $40 | Maintains | Equal-Weight |
| 04/03/2020 | -42.47% | Piper Sandler | $59 → $43 | Maintains | Neutral |
| 04/02/2020 | -38.46% | Credit Suisse | $60 → $46 | Maintains | Outperform |
| 04/02/2020 | -34.45% | Deutsche Bank | $51 → $49 | Maintains | Hold |
| 04/01/2020 | -45.15% | Wells Fargo | $45 → $41 | Maintains | Equal-Weight |
| 04/01/2020 | -38.46% | Oppenheimer | $76 → $46 | Maintains | Outperform |
| 03/30/2020 | -30.43% | Citigroup | $55 → $52 | Maintains | Buy |
| 03/25/2020 | -46.49% | UBS | $64 → $40 | Maintains | Buy |
| 03/23/2020 | -57.19% | B of A Securities | $42 → $32 | Maintains | Buy |
| 03/13/2020 | -42.47% | Goldman Sachs | $52 → $43 | Upgrades | Neutral → Buy |
| 03/04/2020 | — | Citigroup | Upgrades | Neutral → Buy | |
| 02/21/2020 | -18.39% | DA Davidson | $67 → $61 | Downgrades | Buy → Neutral |
| 01/21/2020 | — | Citigroup | Downgrades | Buy → Neutral | |
| 01/17/2020 | -17.06% | B of A Securities | $57 → $62 | Reiterates | → Buy |
| 01/17/2020 | -21.07% | Piper Sandler | → $59 | Downgrades | Overweight → Neutral |
| 01/13/2020 | — | JMP Securities | Downgrades | Market Outperform → Market Perform | |
| 01/09/2020 | -17.06% | DA Davidson | → $62 | Initiates Coverage On | → Buy |
| 01/08/2020 | -17.06% | DA Davidson | → $62 | Initiates Coverage On | → Buy |
| 10/10/2019 | — | Piper Sandler | Upgrades | Hold → Buy | |
| 07/12/2019 | — | Citigroup | Upgrades | Neutral → Buy | |
| 04/18/2019 | — | Citigroup | Downgrades | Buy → Neutral | |
| 03/26/2019 | -18.39% | Oppenheimer | $60 → $61 | Maintains | Outperform |
| 02/01/2019 | — | Societe Generale | Downgrades | Hold → Sell | |
| 01/10/2019 | -35.79% | Citigroup | $50 → $48 | Upgrades | Neutral → Buy |
| 12/07/2018 | -22.41% | Credit Suisse | $62 → $58 | Maintains | Outperform |
| 10/24/2018 | -19.73% | Wells Fargo | $56 → $60 | Upgrades | Market Perform → Outperform |
What is the target price for Morgan Stanley (MS)?
The latest price target for Morgan Stanley (NYSE: MS) was reported by Oppenheimer on October 19, 2023. The analyst firm set a price target for $98.00 expecting MS to rise to within 12 months (a possible 31.10% upside). 39 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Morgan Stanley (MS)?
The latest analyst rating for Morgan Stanley (NYSE: MS) was provided by Oppenheimer, and Morgan Stanley maintained their outperform rating.
When is the next analyst rating going to be posted or updated for Morgan Stanley (MS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Morgan Stanley, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Morgan Stanley was filed on October 19, 2023 so you should expect the next rating to be made available sometime around October 19, 2024.
Is the Analyst Rating Morgan Stanley (MS) correct?
While ratings are subjective and will change, the latest Morgan Stanley (MS) rating was a maintained with a price target of $100.00 to $98.00. The current price Morgan Stanley (MS) is trading at is $74.75, which is out of the analyst's predicted range.
